Please enter keyword
OK
Please enter keyword
OK
Gene Editing
By species
By technologies
CRISPR/EGE™
ESC/HR
Transposon
Other services
By strategies
Animal & Cell Models
Humanized animal models
Immune checkpoint humanized mice
Cytokine humanized mice
GPCR humanized mice
Other humanized mice
KO mouse models
Drug target knockout mice
Other knockout mice
Tool mice
Cre mice
Reporter mice
Other tool mice
Immunodeficient mice/rats
B-NDG series immunodeficient mice
Other immunodeficient mice/rats
Cell lines
Humanized cell lines
Mouse derived cell lines
Reporter cell lines
Other cell lines
Aged mice
Disease mouse models
Oncology Disease
Autoimmune Disease
Nervous System Disease
Metabolic Disease
Orthopedic Disease
Ophthalmic Disease
Cardiovascular diseases
Urinary System Disease
Surgical disease
Rare Disease
Pharmacology Services
Therapeutic area
Oncology
Metabolic diseases
Autoimmune diseases
Inflammatory diseases
Types of services
In vivo pharmacology
Ex vivo pharmacology
In vitro pharmacology
Pharmacokinetics (PK) assays
Pathological/Toxicological assays
Model/method development
Integrated solution
Molecule type
Small molecule
Peptide/protein
Antibody
XDC
Tumor vaccine
Gene therapy
Cell therapy
Technology
In vivo
Ex vivo
In vitro
Resources & Activities
Technical support
Courses
Brochure
Q & A
Publications
News & events
News
Events
Other Services
Microbial detection
Pathogen
Parasite
Virus
Other
Animal Breeding
Animal Cryopreservation
Animal Rederivation
About Us
Biocytogen animal center
Certifications
Join us
Contact us
Biocytogen
English
|
Chinese
English
Chinese
Home
Resources&Activities
Technical support
Publications
B-NDG mice
Text
A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis
Time:2022-11-19
Used in this study:
B-NDG mice
/Uploads/Picture/2022/12/16/u639bdc76af25a.pdf
Share to: